In recent years, an unprecedented level of interest in the promise of psychedelics has taken hold. In the United States, many types of psychedelics are being investigated for use in treating an array of mental health...more
9/14/2023
/ Continuing Legal Education ,
Controlled Substances ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Healthcare Reform ,
Legislative Agendas ,
Mental Health ,
Mental Health Parity Rule ,
Pharmaceutical Industry ,
Webinars